Robert E Conway - Net Worth and Insider Trading
Robert E Conway Net Worth
The estimated net worth of Robert E Conway is at least $29 Million dollars as of 2024-09-20. Robert E Conway is the CEO of Array BioPharma Inc and owns about 656,196 shares of Array BioPharma Inc (ARRY) stock worth over $26 Million. Robert E Conway is the Director of Alpine Immune Sciences Inc and owns about 50,000 shares of Alpine Immune Sciences Inc (ALPN) stock worth over $3 Million. Robert E Conway is also the Chairman of the Board of ARCA biopharma Inc and owns about 4,167 shares of ARCA biopharma Inc (ABIO) stock worth over $106,259. Details can be seen in Robert E Conway's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Robert E Conway has not made any transactions after 2021-09-23 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Robert E Conway
Robert E Conway Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Robert E Conway owns 2 companies in total, including ARCA biopharma Inc (ABIO) , and Alpine Immune Sciences Inc (ALPN) .
Click here to see the complete history of Robert E Conway’s form 4 insider trades.
Insider Ownership Summary of Robert E Conway
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
ABIO | ARCA biopharma Inc | 2021-05-12 | director |
ALPN | Alpine Immune Sciences Inc | 2021-09-23 | director |
Robert E Conway Latest Holdings Summary
Robert E Conway currently owns a total of 3 stocks. Among these stocks, Robert E Conway owns 656,196 shares of Array BioPharma Inc (ARRY) as of June 17, 2011, with a value of $26 Million and a weighting of 88.4%. Robert E Conway owns 50,000 shares of Alpine Immune Sciences Inc (ALPN) as of September 23, 2021, with a value of $3 Million and a weighting of 11.24%. Robert E Conway also owns 4,167 shares of ARCA biopharma Inc (ABIO) as of May 12, 2021, with a value of $106,259 and a weighting of 0.37%.
Latest Holdings of Robert E Conway
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
ARRY | Array BioPharma Inc | 2011-06-17 | 656,196 | 38.95 | 25,558,834 |
ALPN | Alpine Immune Sciences Inc | 2021-09-23 | 50,000 | 64.97 | 3,248,500 |
ABIO | ARCA biopharma Inc | 2021-05-12 | 4,167 | 25.50 | 106,259 |
Holding Weightings of Robert E Conway
Robert E Conway Form 4 Trading Tracker
According to the SEC Form 4 filings, Robert E Conway has made a total of 0 transactions in Array BioPharma Inc (ARRY) over the past 5 years. The most-recent trade in Array BioPharma Inc is the acquisition of 25,000 shares on June 17, 2011, which cost Robert E Conway around $54,250.
According to the SEC Form 4 filings, Robert E Conway has made a total of 4 transactions in Alpine Immune Sciences Inc (ALPN) over the past 5 years, including 3 buys and 1 sells. The most-recent trade in Alpine Immune Sciences Inc is the sale of 15,000 shares on September 23, 2021, which brought Robert E Conway around $151,200.
According to the SEC Form 4 filings, Robert E Conway has made a total of 5 transactions in ARCA biopharma Inc (ABIO) over the past 5 years, including 5 buys and 0 sells. The most-recent trade in ARCA biopharma Inc is the acquisition of 833 shares on May 12, 2021, which cost Robert E Conway around $31,900.
Insider Trading History of Robert E Conway
- 1
Robert E Conway Trading Performance
GuruFocus tracks the stock performance after each of Robert E Conway's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Robert E Conway is -1.38%. GuruFocus also compares Robert E Conway's trading performance to market benchmark return within the same time period. The performance of stocks bought by Robert E Conway within 3 months outperforms 4 times out of 16 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Robert E Conway's insider trading performs compared to the benchmark.
Performance of Robert E Conway
Robert E Conway Ownership Network
Robert E Conway Owned Company Details
What does ARCA biopharma Inc do?
Who are the key executives at ARCA biopharma Inc?
Robert E Conway is the director of ARCA biopharma Inc. Other key executives at ARCA biopharma Inc include 10 percent owner & other: See Footnote 1 Funicular Funds, Lp , other: See Footnote 1 Funicular Fund, Lp , and other: See Remarks Jacob Ma-weaver .
ARCA biopharma Inc (ABIO) Insider Trades Summary
Over the past 18 months, Robert E Conway made no insider transaction in ARCA biopharma Inc (ABIO). Other recent insider transactions involving ARCA biopharma Inc (ABIO) include a net purchase of 634,678 shares made by ,
In summary, during the past 3 months, insiders sold 0 shares of ARCA biopharma Inc (ABIO) in total and bought 52,890 shares, with a net purchase of 52,890 shares. During the past 18 months, 0 shares of ARCA biopharma Inc (ABIO) were sold and 52,890 shares were bought by its insiders, resulting in a net purchase of 52,890 shares.
ARCA biopharma Inc (ABIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
ARCA biopharma Inc Insider Transactions
Robert E Conway Mailing Address
Above is the net worth, insider trading, and ownership report for Robert E Conway. You might contact Robert E Conway via mailing address: C/o Arca Biopharma, Inc, 8001 Arista Place, Ste 430, Broomfield Co 80021.